Clinical Trials Logo

Filter by:
NCT ID: NCT05975268 Recruiting - Clinical trials for Moderate to Severe Chronic Plaque Psoriasis

A Clinical Study to Evaluate the Efficacy and Safety of Subcutaneous JS005 Injection in the Treatment of Adults With Moderate to Severe Chronic Plaque Psoriasis

Start date: August 28, 2023
Phase: Phase 3
Study type: Interventional

This is a multicenter, randomized, double-blind, parallel, placebo-controlled Phase III clinical study to evaluate the efficacy and safety of JS005 in 702 adult patients with moderate-to-severe chronic plaque psoriasis

NCT ID: NCT05975151 Recruiting - Bladder Cancer Clinical Trials

Efficacy and Safety of Pseudomonas Aeruginosa for Intermediate and High-risk Non-muscle Invasive Bladder Cancer

Start date: October 1, 2023
Phase: Phase 2
Study type: Interventional

This is a multicenter, single-arm study to evaluate the efficacy and safety of Pseudomonas aeruginosa the treatment of patients with intermediate and high risk non-muscle invasive bladder cancer. The study continued treatment until the patient could not obtain clinical benefits or had intolerable toxic reactions or the patient withdrew the informed consent, whichever occurred first.

NCT ID: NCT05974904 Recruiting - Liver Fibrosis Clinical Trials

Association of hsCAR With MAFLD and Liver Fibrosis: A Cross-sectional Study

Start date: July 18, 2023
Phase:
Study type: Observational

The goal of this observational study is to investigate the associations between a novel inflammatory marker, high sensitivity C-reactiveprotein to albumin ratio (hsCAR), and steatosis and fibrosis of metabolic dysfunction-associated fatty liver disease (MAFLD). The main question[s] it aims to answer are: [question 1] Can hsCAR serve as a clinical indicator to determine whether a patient has MAFD? [question 2] Can hsCAR determine whether MAFLD patients are complicated with liver fibrosis?

NCT ID: NCT05974761 Recruiting - Low Back Pain Clinical Trials

Clinical Observation on the Treatment of Massage Based on Fascia Chain

Start date: October 21, 2023
Phase: N/A
Study type: Interventional

The goal of thisclinical trial is to observe and quantify the impact of our massage methods on the human body based on B-mode ultrasound, Vas score, and ODI score, and to compare our massage methods with traditional Chinese massage treatment. The main questions it aims to answer are: - To set up our standard operating procedure of massage therapy to adjust the stress line of psoas myofascial chain, and provide a more simple and effective therapy for Chronic low back pain. - try to establish a kind of ultrasonic standard to evaluate the curative effect of treating chronic low back pain. The subjects were randomly divided into two groups, the experimental group and the control group, the experimental group was given our characteristic massage treatment, the control group was given traditional Chinese massage treatment.Both groups were treated once every other day, 3 times a week, 2 weeks as a course of treatment, 2 courses of treatment.

NCT ID: NCT05974670 Recruiting - COPD Clinical Trials

Early Warning Value of Consumer Wearable Devices in AECOPD

EWVCWDC
Start date: June 21, 2022
Phase:
Study type: Observational

This is a prospective, multi-center cohort study. 150 subjects with COPD and in stable stage will be included. Wearable device's physiological parameters will be continually collected, the investigators aim to explore whether consumer wearable devices are useful for early warning deterioration of COPD.

NCT ID: NCT05974449 Recruiting - Clinical trials for Breast Cancer Female

Lactobacillus Vaginalis Capsules for Treatment of Vulvovaginal Atrophy in Young Breast Cancer Patients

Start date: August 24, 2023
Phase: Phase 2
Study type: Interventional

This study is a prospective, randomized controlled, phase II clinical study with a planned enrolment of 60 patients. The study focuses on the efficacy and safety of Lactobacillus vaginalis capsules for the prevention and/or treatment of vulvovaginal symptoms in young breast cancer patients receiving ovarian protection during chemotherapy, in order to improve compliance and quality of life in breast cancer patients.

NCT ID: NCT05974085 Recruiting - Triple Hit Lymphoma Clinical Trials

XPO-1 in Combination With RCHOP for DH/TH Lymphoma

Start date: August 1, 2022
Phase: Phase 2
Study type: Interventional

The purpose of this study was to evaluate the efficacy and safety of Selinexor in combination with RCHOP in first-line treatment of patients with DH or TH lymphoma.

NCT ID: NCT05974007 Recruiting - Clinical trials for Non-Small Cell Lung Cancer

Neoadjuvant Treatment Real-world Clinical Outcomes in NSCLC

NeoR-World
Start date: January 1, 2022
Phase:
Study type: Observational

Despite the clinical success of immune checkpoint blockade (ICB), in neoadjuvant setting, there is still a lack of valid data for operable NSCLC in the real world. This study aim to compare the clinical outcomes (pathologic response rate versus survival) of neoadjuvant immunochemotherapy with neoadjuvant chemotherapy in the real world, to explore the impact of clinicopathological factors on clinical outcomes in neoadjuvant immunochemotherapy setting, and to identify potential neoadjuvant immunochemotherapy beneficiaries.

NCT ID: NCT05973721 Recruiting - Pib Specific Phage Clinical Trials

Clinical Study of Phage Therapy for Chronic Constipation Efficacy and Safety

Start date: July 1, 2023
Phase: N/A
Study type: Interventional

The overall aim was to evaluate the efficacy of PiB-specific phages for the treatment of refractory constipation through clinical studies, primarily for the publication of scientific papers and to guide the development of phage therapies. The purpose of this study will be subdivided into three aspects from three aspects: target exposure level, target occupation, and functional effects after acting on the target, including:1) The distribution of PIB phage in the intestine of patients with refractory constipation;2) The killing effect of PIB phage on PIB bacteria in refractory constipation patients;And 3) therapeutic effect of PIB phage on patients with refractory constipation.

NCT ID: NCT05973097 Recruiting - Oral Lichen Planus Clinical Trials

Treatment of Oral Lichen Planus With Paeoniflorin and Photodynamic Therapy

Start date: July 30, 2023
Phase: N/A
Study type: Interventional

Oral lichen planus (OLP) is a common chronic inflammatory disease of the oral mucosa and is considered a precancerous condition. It is characterized by white reticular changes in the oral mucosa, which can progress to erosions and cause pain in severe cases. The pathogenesis of OLP is still unclear, but it is believed to be a T-lymphocyte-mediated autoimmune disease. Currently, only symptomatic treatments are available, and there is no definitive cure. In this project, we plan to use TCM differentiation to categorize OLP patients and conduct a randomized controlled clinical trial to demonstrate the enhanced therapeutic effect of paeoniflorin combined with photodynamic therapy for OLP. The implementation of this project will provide new insights into the clinical management of OLP, improve our understanding of the treatment mechanisms, and have important theoretical and clinical implications.